XENE
Xenon Pharmaceuticals Inc.- Sector
- Biotechnology
- Last price
- $68.92
- As of
Active signals for XENE
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 7.8% — EPS $-1.31 vs $-1.2153 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 5.8% — EPS $-1.07 vs $-1.0111 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 7.8% — EPS $-1.31 vs $-1.2153 estimate
- mediumEARNINGS_MISS
Q2-2025: Missed consensus by 5.8% — EPS $-1.07 vs $-1.0111 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 7.8% — EPS $-1.31 vs $-1.2153 estimate
Top institutional holders of XENE (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $55.6M | 0.02% | , |
| TWO SIGMA INVESTMENTS, LP | $35.2M | 0.03% | +38.8% |
| MILLENNIUM MANAGEMENT LLC | $28.5M | 0.01% | -54.1% |
| TWO SIGMA INVESTMENTS, LP | $19.6M | 0.03% | , |
| RENAISSANCE TECHNOLOGIES LLC | $17.5M | 0.03% | , |
| MILLENNIUM MANAGEMENT LLC | $11.7M | 0.00% | -68.2% |
| CITADEL ADVISORS LLC | $2.1M | 0.00% | +60.1% |
| D. E. Shaw & Co., Inc. | $1.9M | 0.00% | , |
| D. E. Shaw & Co., Inc. | $1.4M | 0.00% | -36.3% |
| CITADEL ADVISORS LLC | $1.2M | 0.00% | , |
| D. E. Shaw & Co., Inc. | $1.1M | 0.00% | -38.6% |
| Point72 Asset Management, L.P. | $541K | 0.00% | +0.0% |
| Point72 Asset Management, L.P. | $417K | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLC | $209K | 0.00% | , |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, XENE
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
Related tickers
See more XENE signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track XENE in your watchlist and get notified the moment a new signal fires.
Track XENE on Kresmion →